| Financial Year |
March 31 2023 |
| Monetary Funds |
3,862,794,839.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
401,891,333.55 |
| Advances to Suppliers |
1,860,096.31 |
| Other Receivables |
143,906,297.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
175,038,290.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
135,283,477.44 |
| Total Current Assets |
4,720,774,335.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
142,400,347.48 |
| Fixed Assetes |
5,693,275,777.12 |
| Under-construction Projects |
5,008,454,614.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
405,102,588.51 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
464,722,466.09 |
| Deferred Income Tax Assets |
3,288,123,533.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
26,048,741,100.91 |
| Total Assets |
30,769,515,436.38 |
| Short-Term Loans |
6,503,611,111.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
231,312,949.21 |
| Accounts Payable |
2,380,509,725.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
504,526,399.41 |
| Taxes Payable |
102,760,682.00 |
| Interest Payable |
-- |
| Dividend Payable |
602,306.96 |
| Other payables |
501,242,743.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,360,284,655.61 |
| Other Current Liabilities |
22,962,501.94 |
| Sub-Total of Current Liabilities |
17,956,063,075.29 |
| Long-term Loans |
5,995,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,326,699,199.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,087,799,639.22 |
| Deferred Income Tax Liabilities |
265,654,553.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,110,456,221.67 |
| Total Liabilities |
39,066,519,296.96 |
| Paid-In Capital(Or Share Stock) |
400,000,000.00 |
| Capital Surplus |
75,410,363.70 |
| Surplus Reserve |
538,773,444.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-9,589,784,364.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-8,297,003,860.58 |
| Owner's Equity（Stockholder's Equity） |
-8,297,003,860.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,769,515,436.38 |
